Abstract
We described a 32-year-old woman with Huntington's disease (HD) who presented with severe chorea, psychosis and cognitive abnormalities. We started risperidone at 2 mg p.o./d and increased to 4 mg p.o./d after six weeks. Psychotic and motor symptoms were markedly improved. Since there was no change in cognitive functions, we added memantine at 5 mg p.o./d and gradually increased the dose to 20 mg p.o/d after five weeks. We continued risperidone and memantine for nearly six months. The patient did not show any progression of cognitive symptoms or motor abnormalities. We did not observe any psychotic symptoms.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dallocchio C., Buffa C., Tinelli C., Mazzarello P. Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharmacol. 1999 Feb;19(1):101–103. doi: 10.1097/00004714-199902000-00020. [DOI] [PubMed] [Google Scholar]
- Erdemoglu A. Kemal, Boratav C. Risperidone in chorea and psychosis of Huntington's disease. Eur J Neurol. 2002 Mar;9(2):182–183. doi: 10.1046/j.1468-1331.2002.0354e.x. [DOI] [PubMed] [Google Scholar]
- Harvey Philip D., Rabinowitz Jonathan, Eerdekens Marielle, Davidson Michael. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry. 2005 Oct;162(10):1888–1895. doi: 10.1176/appi.ajp.162.10.1888. [DOI] [PubMed] [Google Scholar]
- Heider I., Lehmensiek V., Lenk Th, Müller Th, Storch A. Dopaminergic neurotoxicity of homocysteine and its derivatives in primary mesencephalic cultures. J Neural Transm Suppl. 2004;(68):1–13. doi: 10.1007/978-3-7091-0579-5_1. [DOI] [PubMed] [Google Scholar]
- Lemiere Jurgen, Decruyenaere Marleen, Evers-Kiebooms Gery, Vandenbussche Erik, Dom Rene. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. J Neurol. 2004 Aug;251(8):935–942. doi: 10.1007/s00415-004-0461-9. [DOI] [PubMed] [Google Scholar]
- Sharp A. H., Ross C. A. Neurobiology of Huntington's disease. Neurobiol Dis. 1996 Feb;3(1):3–15. doi: 10.1006/nbdi.1996.0002. [DOI] [PubMed] [Google Scholar]